• 1.

    Barreto EF, et al. Development and feasibility of a multidisciplinary approach to AKI survivorship in care transitions: Research letter. Can J Kidney Health Dis 2022; 9:20543581221081258. doi: 10.1177/20543581221081258

    • Search Google Scholar
    • Export Citation
  • 2.

    Lalonde L, et al. Community pharmacist training-and-communication network and drug-related problems in patients with CKD: A multicenter, cluster-randomized, controlled trial. Am J Kidney Dis 2017; 70: 386396. doi: 10.1053/j.ajkd.2017.05.008

    • Search Google Scholar
    • Export Citation
  • 3.

    Anderegg MD, et al. Pharmacist intervention for blood pressure control in patients with diabetes and/or chronic kidney disease. Pharmacotherapy 2018; 38: 309318. doi: 10.1002/phar.2083

    • Search Google Scholar
    • Export Citation
  • 4.

    Awdishu L, et al. A primer on quality assurance and performance improvement for interprofessional chronic kidney disease care: A path to Joint Commission certification. Pharmacy (Basel) 2019; 7:E83. doi: 10.3390/pharmacy7030083

    • Search Google Scholar
    • Export Citation
  • 5.

    van Berlo-van De Laar IRF, et al. Pharmacist-led medication reviews in pre-dialysis and dialysis patients. Res Social Adm Pharm 2020; 16: 17181723. doi: 10.1016/j.sapharm.2020.02.006

    • Search Google Scholar
    • Export Citation
  • 6.

    Weinhandl ED, et al. Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: A quality improvement report. Am J Kidney Dis 2013; 62: 557567. doi: 10.1053/j.ajkd.2013.02.360

    • Search Google Scholar
    • Export Citation
  • 7.

    El Nekidy WS, et al. Role of nephrology pharmacists in the management of anemia in outpatient dialysis units: A Canadian model. Clin Nephrol 2020; 94: 3642. doi: 10.5414/CN110066

    • Search Google Scholar
    • Export Citation
  • 8.

    Manley HJ, et al. Multidisciplinary medication therapy management and hospital readmission in patients undergoing maintenance dialysis: A retrospective cohort study. Am J Kidney Dis 2020; 76: 1321. doi: 10.1053/j.ajkd.2019.12.002

    • Search Google Scholar
    • Export Citation
  • 9.

    Daifi C, et al. Implementation of a clinical pharmacist in a hemodialysis facility: A quality improvement report. Kidney Med 2021; 3: 241247.e1. doi: 10.1016/j.xkme.2020.11.015

    • Search Google Scholar
    • Export Citation
  • 10.

    Dyer SA, et al. Impact of medication reconciliation by a dialysis pharmacist. Kidney360, May 2022; 3:922925. https://doi.org/10.34067/KID.0007182021

    • Search Google Scholar
    • Export Citation
  • 11.

    Pai AB, et al. Medication reconciliation and therapy management in dialysis-dependent patients: Need for a systematic approach. Clin J Am Soc Nephrol 2013; 8: 19881999. doi: 10.2215/CJN.01420213

    • Search Google Scholar
    • Export Citation

Clinical Pharmacists in Nephrology: A Call for Action

Linda AwdishuLinda Awdishu, PharmD, MAS, FASN, is Division Head and Professor of Clinical Pharmacy at the University of California San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences. She practices at UCSD Health as a pharmacist specialist in kidney diseases and transplantation. Throughout her 20-plus-year career she has developed new, innovative clinical pharmacy practice models, such as interprofessional care in chronic kidney disease, safe drug distribution systems, medication reconciliation, and an innovative med-to-chair program in chronic hemodialysis, as well as discharge education and long-term follow-up clinics in kidney transplantation. She is a nephrology board member for the American Board of Internal Medicine and a member of the ASN Publications Committee.

Search for other papers by Linda Awdishu in
Current site
Google Scholar
PubMed
Close
Restricted access
Save